BURLINGTON, Mass., July 24 /EMWNews/ -- Palomar Medical

Technologies, Inc. (Nasdaq: PMTI), a leading developer of laser- and

light-based devices for hair removal and other cosmetic treatments, will

hold its quarterly conference call of its 2008 second quarter financial

results on Thursday, July 31, 2008 at 11:30AM Eastern Time. If you would

like to participate, please call (866) 362-4831 at 11:20 AM Eastern Time on

that day. The telephone replay will be available one hour after the call at

(888) 286-8010 passcode 86399673 and continue through Thursday, August 14,

2008.



    A live webcast of Palomar's conference call will be available in the

Investor Relations' section of the Company's web site

http://www.palomarmedical.com . Institutional investors can access the call via

Thomson Financial's password-protected event management site, StreetEvents

(http://www.streetevents.com). The online archive will be available one hour after

the call and continue through Thursday, August 14, 2008.



    For more information on Palomar and its products, visit Palomar's

website at http://www.palomarmedical.com. To continue receiving the most

up-to-date information and latest news on Palomar as it happens, sign up to

receive automatic e-mail alerts by going to the Investor Relations' section

of the website.

    About Palomar Medical Technologies Inc: Palomar is a leading researcher

and developer of light-based systems for cosmetic treatments. Palomar

pioneered the optical hair removal field, when, in 1997, it introduced the

first high-powered laser hair removal system. Since then, many of the major

advances in light-based hair removal have been based on Palomar technology.

In December 2006, Palomar became the first company to receive a 510(k)

over-the-counter (OTC) clearance from the United States Food and Drug

Administration (FDA) for a new, patented, home use, light-based hair

removal device. OTC clearance allows the product to be marketed and sold

directly to consumers without a prescription. There are now millions of

light-based cosmetic procedures performed around the world every year in

physician offices, clinics, spas and salons. Palomar is testing many new

and exciting applications to further advance the hair removal market and

other cosmetic applications. Palomar is focused on developing proprietary

light-based technology for introduction to the mass markets. Palomar has

granted The Procter & Gamble Company a non-exclusive License Agreement to

certain patents, technology and FDA documents related to the home-use,

light-based hair removal field for women. In addition, Palomar has an

exclusive development and license agreement with Johnson & Johnson Consumer

Companies to develop and potentially commercialize home-use, light-based

devices for reducing or reshaping body fat including cellulite, reducing

the appearance of skin aging, and reducing or preventing acne.








    Contacts: Kayla Castle

              Investor Relations Manager

              Palomar Medical Technologies, Inc.

              781-993-2411

              [email protected]